Page 1

MLPCARE Stronger Balance Sheet Supported by Increased Efficiency November 4 , 2021 MLP Sağlık Hizmetleri A.Ş. ( “ MLP Care " ) MLP Sağlık Hizmetleri A.Ş. ( BIST : MPARK ) , the leading private healthcare service provider in Turkey , today announces its financial results for the third quarter and the first nine months of 2021 . ( All figures in this fact sheet include the impact of IFRS 16 unless otherwise stated . ) Summary Financials ( TL million ) 9M 2021 Revenues 4,040 9M 2020 2,814 Change 43.6 % Q3 2021 1,498 Q3 2020 1,075 Change 39.3 % EBITDA¹ 1,068 766 39.5 % EBITDA margin ( % ) 26.4 % 27.2 % ( 77bps ) 392 26.2 % 312 26.0 % 29.0 % ( 276bps ) EBITDA¹ ( w / o fx impact ) ² 1,029 693 48.5 % 396 279 42.2 % EBITDA margin ( % ) 25.5 % 24.6 % 84bps 26.4 % 25.9 % 55bps Net Profit / ( Loss ) Before Tax 335 89 276.9 % 147 25 497.0 % Net Profit / ( Loss ) 215 52 315.3 % 41 13 224.4 % Net Profit / ( Loss ) ( allocated to equity holders of the parent ) 165 23 610.3 % 18 ( 4 ) n.m. Free Cash Flow 851 580 46.9 % 335 278 20.7 % Capital Expenditure 245 108 Net Debt³ ( including TFRS 16 impact ) 1,967 2,088 125.8 % ( 5.8 % ) 1,967 76 52 46.7 % 2,088 ( 5.8 % ) 1 Adj . EBITDA is based on reported EBITDA ( Earnings Before Interest , Taxes , Depreciation , and Amortization ) adjusted for one- time ( income ) / expenses , net and non - cash GAAP provision expenses 2 Without fx impact of other income / expenses from operating activities Including obligations under operational leases related to TFRS 16 Financial Highlights ✓ ✓ In Q3 2021 , total revenues increased by 39 % to TL 1,498 million ( Q3 2020 : TL 1,075 million ) . The continued robust uptick in domestic patient revenues quarter - on - quarter and the accelerated recovery of foreign medical tourism business have been the main drivers for the strong performance . Overall , 9M 2021 revenues increased by 44 % to TL 4,040 million ( 9M 2020 : TL 2,814 million ) . In Q3 2021 , the adj . EBITDA ( w / o fx impact ) increased by 42 % to TL 396 million , while adj . EBITDA ( w / o fx impact ) margin increased by 55 bps at 26.4 % . In 9M 2021 , the adj . EBITDA ( w / o fx impact ) increased by 48 % to TL 1,029 million , while the adj . EBITDA ( w / o fx impact ) margin increased by 84 bps to 25.5 % . In Q3 2021 , net profit increased by 224.4 % to TL 41 ( Q3 2020 : TL 13 million ) . It is important to note that this increase is after the one - off deferred tax expense adjustment of TL 69 million related to the tax base increase . Accordingly , net profit in 9M 2021 increased to TL 215 million ( 9M 2020 : TL 52 million ) . Net profit allocated to equity holders of the parent was TL 18 million in Q3 2021 ( Q3 2020 : TL 4 million loss ) . Rapid recovery of revenues compared to previous year , effective cost optimization , and reduction of financial expenses ( realized after closure of FX open position in financial debt in February 2021 ) have supported the net profit increase . MEDICALPARK IV HOSPITAL -1-